Company Filing History:
Years Active: 2015
Title: The Innovations of Marie-Pierre Filliot: A Focus on Pharmaceutical Advancements
Introduction
Marie-Pierre Filliot is an inventive force in the pharmaceutical industry, based in Geispitzen, France. With a dedication to developing innovative treatments, she holds a significant patent that showcases her contribution to modern medicine.
Latest Patents
Filliot's patent, titled "Pharmaceutical compositions, dosage forms and new forms of the compound of formula (I), and methods of use thereof," presents a groundbreaking discovery. This invention introduces a novel crystalline anhydrous form of a complex compound designed for the treatment or prevention of conditions that require platelet ADP receptor inhibition, particularly focusing on P2Y inhibition in humans. The patent outlines not only the unique chemical formulation but also the methods involved in creating this crystalline form and its application in solid oral formulations.
Career Highlights
Filliot has made significant strides in her career, most notably as a part of Portola Pharmaceuticals, Inc. Here, she focuses on the development of innovative pharmaceutical solutions that address pressing medical concerns. Her work reflects a strong commitment to enhancing patient care through advanced therapeutic options.
Collaborations
Throughout her career, Filliot has collaborated with dedicated professionals in her field. One notable coworker is Nicole Bieri, who shares her passion for pharmaceutical innovation. Together, they contribute to the advancement of medical treatments, highlighting the importance of teamwork in scientific research and development.
Conclusion
Marie-Pierre Filliot exemplifies the spirit of innovation in the pharmaceutical industry. Her patent reflects a significant leap in medical treatment options, combining her expertise with collaborative endeavors. As she continues her work at Portola Pharmaceuticals, her contributions will undoubtedly influence future developments in healthcare.